Is fat mass more effective than body mass index (BMI) to predict toxicity in early breast cancer patients treated with doxorubicin and cyclophosphamide?

Basit Öğe Kaydı
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorKavak, Hemrin
dc.contributor.authorUrakci, Zuhat
dc.contributor.authorNas, Necip
dc.contributor.authorOruc, Zeynep
dc.contributor.authorYerlikaya, Halis
dc.contributor.authorAkdeniz, Nadiye
dc.date.accessioned2024-04-24T17:44:33Z
dc.date.available2024-04-24T17:44:33Z
dc.date.issued2018
dc.departmentDicle Üniversitesien_US
dc.descriptionSan Antonio Breast Cancer Symposium -- DEC 05-09, 2017 -- San Antonio, TXen_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.issn0008-5472
dc.identifier.issn1538-7445
dc.identifier.issue4en_US
dc.identifier.urihttps://hdl.handle.net/11468/22150
dc.identifier.volume78en_US
dc.identifier.wosWOS:000425489402221
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherAmer Assoc Cancer Researchen_US
dc.relation.ispartofCancer Research
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleIs fat mass more effective than body mass index (BMI) to predict toxicity in early breast cancer patients treated with doxorubicin and cyclophosphamide?en_US
dc.titleIs fat mass more effective than body mass index (BMI) to predict toxicity in early breast cancer patients treated with doxorubicin and cyclophosphamide?
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu